CTXR (STOCKS)
Citius Pharmaceuticals Inc. Common
$0.899900
+0.088400 (+10.89%)
Prev close: $0.811500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Leonard L. Mazur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20.20M
- Employees
- 23
- P/E (TTM)
- -0.21
- P/B (TTM)
- 0.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$157.70K |
| Operating Expenses | $38.53M |
| Research and Development | $9.16M |
| Other Operating Expenses | $29.37M |
| Operating Income/Loss | -$38.53M |
| Income/Loss From Continuing Operations After Tax | -$39.74M |
| Income/Loss From Continuing Operations Before Tax | -$38.68M |
| Income Tax Expense/Benefit | $1.06M |
| Income Tax Expense/Benefit, Deferred | $1.06M |
| Net Income/Loss | -$39.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$2.31M |
| Net Income/Loss Attributable To Parent | -$37.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$37.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.38 |
| Diluted Earnings Per Share | -$3.38 |
| Basic Average Shares | 11,065,225 |
| Diluted Average Shares | 11,065,225 |
| Assets | $130.94M |
| Current Assets | $27.93M |
| Inventory | $22.29M |
| Prepaid Expenses | $1.40M |
| Other Current Assets | $4.25M |
| Noncurrent Assets | $103.00M |
| Liabilities | $53.41M |
| Current Liabilities | $44.91M |
| Accounts Payable | $13.69M |
| Wages | $3.29M |
| Other Current Liabilities | $27.93M |
| Noncurrent Liabilities | $8.50M |
| Equity | $77.53M |
| Equity Attributable To Noncontrolling Interest | $9.98M |
| Equity Attributable To Parent | $67.55M |
| Liabilities And Equity | $130.94M |
| Net Cash Flow From Operating Activities | -$26.55M |
| Net Cash Flow From Operating Activities, Continuing | -$26.55M |
| Net Cash Flow From Investing Activities | -$5.75M |
| Net Cash Flow From Investing Activities, Continuing | -$5.75M |
| Net Cash Flow From Financing Activities | $33.30M |
| Net Cash Flow From Financing Activities, Continuing | $33.30M |
| Net Cash Flow | $1.00M |
| Net Cash Flow, Continuing | $1.00M |
| Comprehensive Income/Loss | -$39.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.74M |
| Other Comprehensive Income/Loss | $0.00 |